Dmytro Shymkiv, the former deputy head of the Presidential Administration of Ukraine, has taken on the role of chairman of the board at the managing company of PrJSC Pharmaceutical Firm Darnitsa. According to the company’s press release, Shymkiv’s responsibilities as the newly elected top-manager include overseeing international affairs, strategic planning, development, and the implementation of new technologies.
Expressing his enthusiasm for the challenge, Shymkiv stated, “Darnitsa is a modern, dynamic, and profitable Ukrainian company. It is an interesting challenge for me as a businessman to elevate it to the ranks of international pharmaceutical players. It is also appealing to me that Darnitsa not only creates added value in its production in Ukraine but also invests it in Ukraine.”
Shymkiv highlighted the active growth of Ukraine’s pharmaceutical market and the promising outlook for Ukrainian-made concepts on the international stage. He believes that the medical industry and pharmaceuticals will shape economic and innovative trends over the next 25 years, much like IT has done in the past 25 years.
Looking ahead, Dmytro Shymkiv revealed his plans to serve as a board member in several IT companies over the next few years, as he has already received offers to join their top management.
Born on September 28, 1975, in Lviv, Dmytro Shymkiv has a background in top management, having worked in innovation companies in Ukraine, Europe, and the USA since 1998. His career includes a tenure at “Microsoft Ukraine” from 2007 to 2014, where he served as the head of the company’s branch in Ukraine.
During his four-year term as deputy head of the Presidential Administration of Ukraine starting in July 2014, Shymkiv played a pivotal role in various initiatives, such as the creation of the National Reforms Council, the introduction of 3G and 4G in Ukraine, the launch of the electronic public procurement system ProZorro, and the development of a sustainable strategy called “Ukraine-2020.” He also contributed to the launch of the GoGlobal project, aimed at promoting English language studies.
PrJSC Pharmaceutical Firm Darnitsa, founded in 1930, stands as a leading pharmaceutical producer in Ukraine, with a portfolio comprising around 250 brands of different medications. In 2017, the company achieved sales of 2.53 billion hryvnyas, marking a 19% increase from 2016. The ultimate beneficiary of the pharmaceutical firm is the Zagoriys family, which includes Hlib Zagoriy, a member of the Ukrainian parliament of the eighth convocation.
In related news, on July 25, Volodymyr Kostyuk assumed the role of executive director at PAO Farmak (Kyiv), succeeding his predecessor Avgustin Dubnichka, who held the position until March 2018.